Events & presentations

Financial & IR calendar

Degroof Petercam’s Healthcare Conference

26 January 2023
Brussels

Investor Relations
presentation

Investor Relations
factsheet

Investor
Day

Presentations & webcasts

Material
Date
View

Efficacy and Safety of Estetrol (E4), a Promising New Treatment for Menopausal Vasomotor Symptoms: Results of a randomized, double- blind, placebo-controlled Phase 3 trial (North American Menopause Society 2022 meeting 12-15 Oct, Atlanta, GA)

14 October 2022

Estetrol (E4), a landmark in the making? Before and beyond reproductive age: new therapeutic opportunities for E4 ⁠- Report on Scientific Symposium (20th ISGE World Congress)

13 June 2022

2021 Annual Results Webcast

8 March 2022

Donesta® Top-Line Results Phase 3

14 January 2022

2021 Investor Day Webcast

29 November 2021

2021 Half Year Results Webcast

24 September 2021

Estrogens: Harnessing the power of nature against Covid-19 and emerging viral infections – Presentation

28 May 2021

2020 Annual Results Webcast (9.30 CET) ( Virtual )

9 March 2021

Half Year Results Webcast (3:00PM CEST) ( Virtual )

24 September 2020

Jefferies Healthcare Conference – Mithra Presentation – Webcast

3 June 2020

Share price

29/11/2022 17:35 (Euronext Brussels)

€ 4.42

-0.16

(-3.39%)

Calendar & events

Degroof Petercam’s Healthcare Conference
26 January 2023
Brussels

Investor Relations

Benoît Mathieu

Get the latest news: subscribe to our Newsletter!